U6 is unsuitable for normalization of serum miRNA levels in patients with sepsis or liver fibrosis

Experimental and Molecular Medicine

Volumn 45, Issue 9, 2013, Pages

  Benz, Fabian ^a   Roderburg, Christoph ^a   Cardenas, David Vargas ^a   Vucur, Mihael ^a   Gautheron, Jérémie ^a   Koch, Alexander ^a   Zimmermann, Henning ^a   Janssen, Jörn ^a   Nieuwenhuijsen, Lukas ^a   Luedde, Mark ^b   Frey, Norbert ^b   Tacke, Frank ^a   Trautwein, Christian ^a   Luedde, Tom ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

miRNA; Normalization; Serum; Spiked in miRNA; U6

Indexed keywords

APRIL PROTEIN; C REACTIVE PROTEIN; CYSTATIN C; D DIMER; INSULIN; INTERLEUKIN 10; LACTATE DEHYDROGENASE; MICRORNA; PROCALCITONIN; RESISTIN; SMALL NUCLEAR RNA; SMALL NUCLEAR RNA U6; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; UROKINASE RECEPTOR; U6 SMALL NUCLEAR RNA; VIRUS T ANTIGEN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; CRITICAL ILLNESS; DOWN REGULATION; FEMALE; HUMAN; INTESTINE SURGERY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; SEPSIS; UPREGULATION; ADOLESCENT; ANIMAL; BLOOD; C57BL MOUSE; CASE CONTROL STUDY; LIVER CIRRHOSIS; MIDDLE AGED; REFERENCE VALUE; VERY ELDERLY;

MUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; CASE-CONTROL STUDIES; DOWN-REGULATION; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; REFERENCE VALUES; RNA, SMALL NUCLEAR; SEPSIS;

EID: 84885090820     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2013.81     Document Type: Article

References (46)

1. Roderburg C, Trautwein C, Luedde T. MicroRNA-199a/b-3p: A new star in the liver microcosmos. Hepatology 2011; 54: 729-731
2. Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, Montgomery CL, Hwang HW et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 2009; 137: 1005-1017
3. Roderburg C, Urban GW, Bettermann K, Vucur M, Zimmermann H, Schmidt S et al. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 2011; 53: 209-218
4. Mott JL, Kobayashi S, Bronk SF, Gores GJ. mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 2007; 26: 6133-6140
5. Pineau P, Volinia S, McJunkin K, Marchio A, Battiston C, Terris B et al. miR-221 overexpression contributes to liver tumorigenesis. Proc Natl Acad Sci USA 2010; 107: 264-269
6. Reid G, Kirschner MB, van Zandwijk N. Circulating Micrornas: Association with disease and potential use as biomarkers. Crit Rev Oncol Hematol 2011; 80: 193-208
7. Roderburg C, Luedde M, Vargas Cardenas D, Vucur M, Scholten D, Frey N et al. Circulating microRNA-150 serum levels predict survival in patients with critical illness and sepsis. PLoS One 2013; 8: E54612
8. Vasilescu C, Rossi S, Shimizu M, Tudor S, Veronese A, Ferracin M et al. MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis. PLoS One 2009; 4: 0007405
9. Roderburg C, Mollnow T, Bongaerts B, Elfimova N, Vargas Cardenas D, Berger K et al. Micro-RNA profiling in human serum reveals compartmentspecific roles of miR-571 and miR-652 in liver cirrhosis. PLoS One 2012; 7: E32999
10. Lino Cardenas CL, Henaoui IS, Courcot E, Roderburg C, Cauffiez C, Aubert S et al. miR-199a-5p is upregulated during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting caveolin-1. PLoS Genet 2013; 9: E1003291
11. Elfimova N, Schlattjan M, Sowa JP, Dienes HP, Canbay A, Odenthal M. Circulating Micrornas: Promising candidates serving as novel biomarkers of acute hepatitis. Front Physiol 2012; 3: 21
12. Kong YW, Ferland-McCollough D, Jackson TJ, Bushell M. Micrornas in cancer management. Lancet Oncol 2012; 13: E249-e258
13. Lowery AJ, Miller N, McNeill RE, Kerin MJ. Micrornas as prognostic indicators and therapeutic targets: Potential effect on breast cancer management. Clin Cancer Res 2008; 14: 360-365
14. Ng EK, Chong WW, Jin H, Lam EK, Shin VY, Yu J et al. Differential expression of Micrornas in plasma of patients with colorectal cancer: A potential marker for colorectal cancer screening. Gut 2009; 58: 1375-1381
15. Fiedler SD, Carletti MZ, Christenson LK. Quantitative RT-PCR methods for mature microRNA expression analysis. Methods Mol Biol 2010; 630: 49-64
16. Zhang Y, Jia Y, Zheng R, Guo Y, Wang Y, Guo H et al. Plasma microRNA- 122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases. Clin Chem 2010; 56: 1830-1838
17. Wang H, Zhang P, Chen W, Feng D, Jia Y, Xie L. Serum microRNA signatures identified by Solexa sequencing predict sepsis patients' mortality: A prospective observational study. PLoS One 2012; 7: 15
18. Ji F, Yang B, Peng X, Ding H, You H, Tien P. Circulating Micrornas in hepatitis B virus-infected patients. J Viral Hepat 2011; 18: 1365-2893
19. Liu J, Mao Q, Liu Y, Hao X, Zhang S, Zhang J. Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients. Chin J Cancer Res 2013; 25: 46-54
20. Ding X, Ding J, Ning J, Yi F, Chen J, Zhao D et al. Circulating microRNA-122 as a potential biomarker for liver injury. Mol Med Rep 2012; 5: 1428-1432
21. Qi R, Weiland M, Gao XH, Zhou L, Mi QS. Identification of endogenous normalizers for serum Micrornas by microarray profiling: U6 small nuclear RNA is not a reliable normalizer. Hepatology 2012; 55: 1640-1642. author reply 1642-1643
22. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K et al. Characterization of Micrornas in serum: A novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008; 18: 997-1006
23. Huang Z, Huang D, Ni S, Peng Z, Sheng W, Du X. Plasma Micrornas are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 2010; 127: 118-126
24. Mi QS, Weiland M, Qi RQ, Gao XH, Poisson LM, Zhou L. Identification of mouse serum miRNA endogenous references by global gene expression profiles. PLoS One 2012; 7: 10
25. Mestdagh P, Van Vlierberghe P, De Weer A, Muth D, Westermann F, Speleman F et al. A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol 2009; 10: 2009-2010
26. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova- Agadjanyan EL et al. Circulating Micrornas as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008; 105: 10513-10518
27. Cermelli S, Ruggieri A, Marrero JA, Ioannou GN, Beretta L. Circulating Micrornas in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PLoS One 2011; 6: 23
28. Zhu W, Qin W, Atasoy U, Sauter ER. Circulating Micrornas in breast cancer and healthy subjects. BMC Res Notes 2009; 2: 89
29. Wang JF, Yu ML, Yu G, Bian JJ, Deng XM, Wan XJ et al. Serum miR-146a and miR-223 as potential new biomarkers for sepsis. Biochem Biophys Res Commun 2010; 394: 184-188
30. Scheffer AR, Holdenrieder S, Kristiansen G, von Ruecker A, Muller SC, Ellinger J. Circulating Micrornas in serum: Novel biomarkers for patients with bladder cancer? World J Urol (e-pub ahead of print 25 December 2012; doi:10.1007/s00345-012-1010-2
31. Oshikawa Y, Jinnin M, Makino T, Kajihara I, Makino K, Honda N et al. Decreased miR-7 expression in the skin and sera of patients with dermatomyositis. Acta Derm Venereol 2012; 93: 273-276
32. Koch A, Voigt S, Kruschinski C, Sanson E, Duckers H, Horn A et al. Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients. Crit Care 2011; 15: 16
33. Koch A, Voigt S, Sanson E, Duckers H, Horn A, Zimmermann HW et al. Prognostic value of circulating amino-terminal pro-C-type natriuretic peptide in critically ill patients. Crit Care 2011; 15: R45
34. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36: 296-327
35. Reinhart K, Brunkhorst FM, Bone HG, Bardutzky J, Dempfle CE, Forst H et al. Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency Medicine (Deutsche Interdisziplinare Vereinigung fur Intensiv- und Notfallmedizin (DIVI)). Ger Med Sci 2010; 8: Doc14
36. Zimmermann HW, Seidler S, Nattermann J, Gassler N, Hellerbrand C, Zernecke A et al. Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis. PLoS One 2010; 5: E11049
37. Sander LE, Sackett SD, Dierssen U, Beraza N, Linke RP, Muller M et al. Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. J Exp Med 2010; 207: 1453-1464
38. Jungebluth P, Alici E, Baiguera S, Le Blanc K, Blomberg P, Bozoky B et al. Tracheobronchial transplantation with a stem-cell-seeded bioartificial nanocomposite: A proof-of-concept study. Lancet 2011; 378: 1997-2004
39. Roderburg C, Koch A, Tacke F, Nieuwenhuijsen L, Bruensing J, Vargas Cardenas D et al. Serum concentrations of A Proliferation-Inducing Ligand (APRIL) are elevated in sepsis and predict mortality in critically ill patients. J Crit Care 2013; 9441: 00474-1
40. Koch A, Gressner OA, Sanson E, Tacke F, Trautwein C. Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients. Crit Care 2009; 13: 19
41. Tacke F, Luedde T, Trautwein C. Inflammatory pathways in liver homeostasis and liver injury. Clin Rev Allergy Immunol 2009; 36: 4-12
42. Xu J, Wu C, Che X, Wang L, Yu D, Zhang T et al. Circulating Micrornas, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. Mol Carcinog 2011; 50: 136-142
43. Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci USA 2013; 110: 3507-3512
44. Roderburg C, Luedde M, Vargas Cardenas D, Vucur M, Mollnow T, Zimmermann HW et al. miR-133a mediates TGF-beta-dependent derepression of collagen synthesis in hepatic stellate cells during liver fibrosis. J Hepatol 2013; 58: 736-742
45. Schmidt WM, Spiel AO, Jilma B, Wolzt M, Muller M. In vivo profile of the human leukocyte microRNA response to endotoxemia. Biochem Biophys Res Commun 2009; 380: 437-441
46. Janiszewski M, Do Carmo AO, Pedro MA, Silva E, Knobel E, Laurindo FR. Platelet-derived exosomes of septic individuals possess proapoptotic NAD(P)H oxidase activity: A novel vascular redox pathway. Crit Care Med 2004; 32: 818-825